Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Treatments for Problems from Anticancer Drugs
Uncategorized

Treatments for Problems from Anticancer Drugs

By medwebMay 1, 2006
Share
Facebook Twitter Email

May 18, 2006

Program Launched to Treat Skin Problems from Anticancer Drugs

CHICAGO—Northwestern University has launched the nation’s first program to treat skin conditions resulting from anticancer drugs.

The Cancer Skin Care (Cancer Study of Chemotherapy-Induced Cutaneous Adverse Reactions) Program was established to develop research and clinical management strategies for skin conditions in cancer patients or those conditions that arise as a result of anticancer therapies. Drugs against cancer can frequently lead to side effects in the skin, which may lead to interruption of lifesaving anticancer treatments.

One of the first successful efforts of the Cancer Skin Care Program is a clinic formed by a group of specialists addressing skin and eye effects of newer anticancer drugs, described in the May issue of the Journal of Supportive Oncology.

The study addresses side effects of targeted therapies, a new group of drugs that directly block proteins involved in cancer. Targeted therapies include the epidermal growth factor receptor (EGFR) and other kinase inhibitors, which have been used successfully to treat head and neck, lung, colorectal, kidney, and pancreatic cancers.

Although these drugs do not have the diffuse and bone marrow side effects of conventional chemotherapy, 60 percent of patients will develop facial acne-like rashes, swelling, and dry, irritated skin. Many of these patients also experience abnormal eyelash growth, dry eye, and other eye disorders that may cause significant discomfort and blurred vision.

Further complicating the dramatic skin reactions is the psychological and physical distress to the patient, said Mario E. Lacouture, MD, assistant professor of dermatology, at Northwestern University’s Feinberg School of Medicine, who heads the Cancer Skin Care Program and is lead author on the study. Dr. Lacouture is a dermatologist at the Northwestern Medical Faculty Foundation and Northwestern Memorial Hospital and a researcher at The Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

“Many patients who experience chemotherapy-induced skin reactions don’t want to leave their homes, and some would rather stop their chemotherapy than live with the discomfort and anxiety. Improving their quality of life is a paramount concern,” Dr. Lacouture said.

The Cancer Skin Care Program includes dermatologists, cancer specialists, ophthalmologists, and basic scientists from the Feinberg School and Cancer Center.

The multidisciplinary clinic focuses on early diagnosis and treatment of reactions to targeted anticancer drugs and patient education to ensure compliance with chemotherapy regimens and minimize the need for drug dose decrease, interruption, or discontinuation.

The enhanced communication between the Cancer Skin Care Program’s specialists has created new opportunities for patient care, education, and research, Dr. Lacouture said.

Another Cancer Skin Care Program specialist (and co-author on the article) is Surendra Basti, MD, associate professor of ophthalmology at the Feinberg School, who focuses on eye complications to anticancer therapies.

The Cancer Skin Care Program is supported by a Zell Scholarship awarded to Dr. Lacouture.

For information on the Cancer Skin Care Program, call 312/695-8106.

Share. Facebook Twitter Email

Related Posts

Lurie Cancer Center Receives Merit Extension from NCI

Oct 20, 2021

Drug Combination May Reduce Risk of Leukemia Relapse

Mar 26, 2020

Rewriting the Role of a Transcription Factor

Mar 19, 2020

Comments are closed.

Latest News

Student Spearheads Ukraine Aid Efforts

Jun 27, 2022

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
pride7
pride6
pride5
pride4
pride3
pride2
pride1
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.